No Increase in Malignancy Risk with Cladribine Tablets in Patients with Relapsing Multiple Sclerosis

Autor: Galazka, A., Nolting, A., Cook, S., Leist, T., Comi, G., Montalban, X., Hicking, C., Dangond, F.
Zdroj: In Multiple Sclerosis and Related Disorders November 2018 26:261-261
Databáze: ScienceDirect